Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
National Health Investors ( (NHI) ) has provided an announcement.
On May 21, 2025, National Health Investors, Inc. held its 2025 Annual Meeting of Stockholders, where 80.26% of the company’s common stock was represented. During the meeting, four directors were elected, an amendment to declassify the board was approved, executive compensation was affirmed, and BDO USA, P.C. was ratified as the independent auditor for 2025.
The most recent analyst rating on (NHI) stock is a Buy with a $80.00 price target. To see the full list of analyst forecasts on National Health Investors stock, see the NHI Stock Forecast page.
Spark’s Take on NHI Stock
According to Spark, TipRanks’ AI Analyst, NHI is a Outperform.
National Health Investors exhibits strong financial performance and positive earnings sentiment, driving its overall score. However, technical indicators suggest limited short-term upside, and valuation appears stretched relative to sector peers. The company’s solid dividend yield and healthy acquisition pipeline are key positives.
To see Spark’s full report on NHI stock, click here.
More about National Health Investors
National Health Investors, Inc. operates in the healthcare real estate investment trust (REIT) industry, focusing on owning and financing healthcare properties. The company primarily invests in senior housing and medical office buildings, catering to the aging population and healthcare providers.
Average Trading Volume: 241,795
Technical Sentiment Signal: Strong Buy
Current Market Cap: $3.43B
See more data about NHI stock on TipRanks’ Stock Analysis page.